In this article, we will look at the 7 Best Robotic Surgery Stocks to Buy.
On May 20, Todd Sohn, Strategas Securities, appeared on CNBC’s ‘Power Lunch’ to discuss how investors should view the equity markets. Talking about whether traders should use the Nvidia report and its influence on the broader AI and chip trade as a reason to reassess their overall risk profiles, he was of the view that this is a great time to derisk portfolios to hedge, to go to the alternative route, manage futures, and even consider stuff life low vol activity, which has not been on the playing field for quite some time. According to him, this is a great time to diversify, just in case things start to get a little bit bumpier. He further said that they have seen volatility really start to pick up in that space.
READ NOW: 10 Best Airline Stocks to Buy According to Reddit AND 9 Best Communication Stocks to Invest In.
Sohn believes that high versus low beta performance is at an extreme, and levered activity is exploding. He does not necessarily call them “sell” signals, but rather focuses on thinking about how to protect and diversify the core of your portfolios. He added that semis are at 18% of the S&P 500, which is one of the highest on record.
With these broader market trends in view, let’s narrow down and look at the best robotic surgery stocks to buy.
Our Methodology
We used stock screeners and online sources to identify the best robotic surgery stocks and selected the top 7 stocks most popular among hedge funds as of Q4 2025, using the hedge fund sentiment data from Insider Monkey’s database. The stocks are arranged in ascending order of hedge fund sentiment.
Note: All data was recorded on May 20.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
7 Best Robotic Surgery Stocks to Buy
7. Smith & Nephew plc (NYSE:SNN)
Number of Hedge Fund Holders: 14
Smith & Nephew plc (NYSE:SNN) is one of the best robotic surgery stocks to buy. Bernstein cut the price target on Smith & Nephew plc (NYSE:SNN) to $31.85 from $36.20 on May 11, maintaining a Market Perform rating on the shares. The rating update came after the company provided a fiscal Q1 trading update on May 6, with the firm noting that reported sales were up 3.1% organically, missing consensus growth of 3.8%.
Smith & Nephew plc (NYSE:SNN) also received a rating update from Canaccord the same day, with the firm cutting the price target on the stock to $30 from $32 and maintaining a Hold rating on the shares. The firm updated its model on the stock after its fiscal Q1 results to take into account comp-group compression.
In its financial results for fiscal Q1 2026, Smith & Nephew plc (NYSE:SNN) reported revenue of $1,501 million, with underlying revenue growth of 3.1%, and reported revenue growth of 6.6%, which included a 350bps foreign exchange tailwind.
Smith & Nephew plc (NYSE:SNN) develops, manufactures, markets, and sells medical devices. Its operations are divided into the following segments: Orthopedics, Sports Medicine and ENT, and Advanced Wound Management.
6. PROCEPT BioRobotics Corporation (NASDAQ:PRCT)
Number of Hedge Fund Holders: 26
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best robotic surgery stocks to buy. PROCEPT BioRobotics Corporation (NASDAQ:PRCT) received several rating updates following the release of its financial results for fiscal Q1.
Piper Sandler lifted the price target on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) to $35 from $28 on April 30, maintaining an Overweight rating on the shares and noting that the company reported fiscal Q1 results that beat on the top-line and reiterated full-year guidance across all key metrics. The firm further stated that the quarter was marked by strong domestic capital placements with impressive all-time high ASPs, which resulted in the stock trading up more than 10% after hours.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) also received a rating update from Baird the same day, with the firm lifting the price target on the stock to $28 from $27 and maintaining a Neutral rating on the shares. The firm stated that it updated its model after its fiscal Q1 beat results. However, it added that the long-term adoption trajectory is keeping them on the sidelines.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is a commercial-stage surgical robotics company that develops transformative solutions for urology. The company manufactures and sells the AquaBeam Robotic System, which is an image-guided, surgical robotic system used in minimally invasive urologic surgery.
While we acknowledge the potential of PRCT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PRCT and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Best Robotic Surgery Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
